Sarah P. Psutka, Bernardo Herrera Imbroda, Paul Crispen, Andrea Necchi, Rohan Garje, Bernadett Emma Szabados, Charles Peyton, Benjamin Pradere, Neal D. Shore, Martin Boegemann, Mark Preston, Evanguelos Xylinas, Cinty Gong, Mohamad Hasan, Hind Stitou, Sumeet Kaur Bhanvadia, Won Kim, Félix Guerrero-Ramos. "Neoadjuvant (Neoadj) gemcitabine intravesical system (Gem-iDRS) plus cetrelimab (CET) or CET alone in patients (pts) with muscle-invasive bladder cancer (MIBC) ineligible for/refusing neoadj cisplatin-based chemotherapy (NAC): Updated perioperative outcomes from SunRISe-4.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.748